Skip to main content

Research positions under an ICMR-funded project at AIIMS

Post Graduate Degree, including the integrated PG degrees/for Engineering / IT / CS - Four Years Graduate degree. 
Post Graduate Professional Require at INST Mohali
First Class Post Graduate Degree, including the integrated PG Degrees (Computational Biology / Chemistry / Physical Chemistry /Bio-Sciences / Bioinformatics) and also qualified in national level eligibility tests.
Openings for Pharmacists in ECHS Polyclinics Mhow and Ujjain
BPharmacy from a recognized Institute Or Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy Council of India and registered as Pharmacist under the Pharmacy Act 1948 Minimum 03 yrs experience
Campus Recruitment Drive at P. R. Pote Patil College of Pharmacy
Advantmed helps health plans and providers improve their risk adjustment, quality improvement, and health assessment programs with market-leading accuracy, flexibility, and transparency.
Multiple Openings for Pharma and Science candidates at Endoc Biotech
Endoc Biotech is an innovation-driven biotech company, specializing in the Fermentation based Active Pharmaceutical Ingredients (APIs) manufacturing company.
Labcorp looking for Quality Reviewer
Responsible for pursuing an understanding of services related to the different clusters and client-specific requests. Manage and solve changes, issues, and concerns of varied complexity, work with little to no guidance, but require some guidance for complex work
Interview for Analytical Development and QC Department at Accuprec Research
Accuprec Research Labs Pvt Ltd. is FDCA approved, OECD-GLP, NABL accredited and ISO 9001:2015 certified CRO
Manufacturing, Packing and QMS Jobs at Intas Pharma
BPharmacy/ M.Pharmacy / M. Sc / B. Sc / Diploma jobs at Intas. Oral Solid, INJECTABLE - Manufacturing and Packing, QMS
ALS Global Hiring Scientist / Associate Scientist
PhD in Analytical Chemistry, Biochemistry or a related field required. Fresh graduates are encouraged to apply 
Johnson & Johnson Reports Encouraging Late-Stage Results for Novel Head and Neck Cancer Therapy

OrigAMI-4 study shows strong tumor responses in patients with recurrent or metastatic head and neck cancer after standard treatments fail. Johnson & Johnson has announced promising clinical results for its investigational therapy RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) in patients with advanced head and neck squamous cell carcinoma (HNSCC), a disease where treatment options remain limited once standard therapies stop working.